Chinese Premier Li Qiang has called for stronger policy support for the biotech industry, as part of efforts to bolster…
Read More »out-licensing
GlaxoSmithKline (GSK) will pay a Chinese company US$12.5 billion for exclusive global rights to develop a dozen drugs, in a…
Read More »